Literature DB >> 12773869

[Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort].

H Ramaroson1, C Helmer, P Barberger-Gateau, L Letenneur, J-F Dartigues.   

Abstract

The progression of the prevalence of dementia in developed countries will increase the difficulties of medical and psycho-social management of demented patients and their family. The aim of this study was to estimate the prevalence of dementia among subjects aged 75 years and over. These subjects have been followed-up ten years after the baseline examination of the PAQUID study, a prospective population-based cohort study on normal and pathological aging after 65 years. A total of 1,461 subjects, aged 75 years and over, have been visited. The prevalence of dementia was estimated to be at 17.8 p.cent. About 38.5 p.cent of these demented subjects ware living in an institution, which leads to the fact that more than the two thirds of the subjects living in an institution were demented persons. Alzheimer's disease was the main etiology of dementia (79.6 p.cent). Based on the French population census, currently there would be about 769,000 demented people aged 75 years or over in France. Dementia accounts for 72 p.cent of the potential need for the French subvention for dependent persons, called Allocation Personnalisee d'Autonomie P. These results point out the importance of regarding dementia as a Public Health priority and of developing necessary measures for caring for these subjects, whether residing in their home or an institution.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773869

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  17 in total

1.  Mild Alzheimer's disease: a "position paper".

Authors:  J Delrieu; T Voisin; S Andrieu; S Belliard; J Belmin; F Blanchard; M Ceccaldi; J F Dartigues; B Defontaines; S Lehericy; C Mekies; O Moreaud; L Naccache; F Nourhashemi; P J Ousset; F Pasquier; P Payoux; F Puisieux; P Robert; J Touchon; B Vellas; B Dubois
Journal:  J Nutr Health Aging       Date:  2009-06       Impact factor: 4.075

2.  How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050.

Authors:  T Mura; J-F Dartigues; C Berr
Journal:  Eur J Neurol       Date:  2009-10-01       Impact factor: 6.089

3.  Older age at retirement is associated with decreased risk of dementia.

Authors:  Carole Dufouil; Edwige Pereira; Geneviève Chêne; M Maria Glymour; Annick Alpérovitch; Elodie Saubusse; Mathilde Risse-Fleury; Brigitte Heuls; Jean-Claude Salord; Marie-Anne Brieu; Françoise Forette
Journal:  Eur J Epidemiol       Date:  2014-05-04       Impact factor: 8.082

4.  Nutritional assessment and follow-up of residents with and without dementia in nursing homes in the Limousin region of France: a health network initiative.

Authors:  P Jesus; J C Desport; A Massoulard; C Villemonteix; A Baptiste; L Gindre-Poulvelarie; S Lorgueuilleux; V Javerliat; J L Fraysse; P M Preux
Journal:  J Nutr Health Aging       Date:  2012-05       Impact factor: 4.075

5.  Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force).

Authors:  S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-10       Impact factor: 4.075

6.  Risks and advantages of detecting individuals unfit to drive: a Markov decision analysis.

Authors:  Sandy Leproust; Emmanuel Lagarde; Louis-Rachid Salmi
Journal:  J Gen Intern Med       Date:  2008-09-09       Impact factor: 5.128

7.  Substitute consent for research involving the elderly: a comparison between Quebec and France.

Authors:  Gina Bravo; Anne-Marie Duguet; Marie-France Dubois; Cyrille Delpierre; Bruno Vellas
Journal:  J Cross Cult Gerontol       Date:  2008-09

8.  Support vector machine-based classification of Alzheimer's disease from whole-brain anatomical MRI.

Authors:  Benoît Magnin; Lilia Mesrob; Serge Kinkingnéhun; Mélanie Pélégrini-Issac; Olivier Colliot; Marie Sarazin; Bruno Dubois; Stéphane Lehéricy; Habib Benali
Journal:  Neuroradiology       Date:  2008-10-10       Impact factor: 2.804

9.  Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).

Authors:  Neda Tavassoli; Agnes Sommet; Maryse Lapeyre-Mestre; Haleh Bagheri; Jean-Louis Montrastruc
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

10.  20-Year prevalence projections for dementia and impact of preventive policy about risk factors.

Authors:  Hélène Jacqmin-Gadda; Annick Alperovitch; Claire Montlahuc; Daniel Commenges; Karen Leffondre; Carole Dufouil; Alexis Elbaz; Christophe Tzourio; Joël Ménard; Jean-François Dartigues; Pierre Joly
Journal:  Eur J Epidemiol       Date:  2013-06-12       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.